Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3b Single-Arm, Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis

NCT01478971 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT01478971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01478971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3b Single-Arm, Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on Dialysis
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2011
Completion date
February 28, 2013
Enrollment
184 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, chronic kidney disease